| Dr Megan Elizabeth Skinner, MD | |
|
Camp Foster, Fpo, AP 96362-0017 | |
| (098) 971-9355 | |
| Not Available |
| Full Name | Dr Megan Elizabeth Skinner |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | Camp Foster, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942561261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101254666 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Megan Elizabeth Skinner, MD Psc 482 Box 1600, Fpo, AP 96362-0017 Ph: () - | Dr Megan Elizabeth Skinner, MD Camp Foster, Fpo, AP 96362-0017 Ph: (098) 971-9355 |
News Archive
Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either lenalidomide (REVLIMID), melphalan and prednisone or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of lenalidomide plus low-dose dexamethasone (Rd) were presented at the American Society of Clinical Oncology annual meeting.
Drug company Celgene says it has halted a pivotal-stage trial of its Thalomid drug earlier than expected after the drug was shown to dramatically limit the progress of the blood cancer multiple myeloma.
A new study by the University of Kentucky Markey Cancer Center shows that patients reported significant improvement in side effects of cancer treatment following just one Jin Shin Jyutsu session. Jin Shin Jyutsu is an ancient form of touch therapy similar to acupuncture in philosophy.
PositiveID Corporation commented today on Digital Angel Corporation's response to the Company's proposal to acquire all of the outstanding common stock of DIGA through a merger transaction. Prior to the commencement of trading on September 16th, PositiveID made a firm offer to purchase all of the outstanding shares of DIGA's common stock at an exchange ratio of .67 shares of PositiveID for each share of DIGA, representing a 60 percent premium to DIGA's average closing price for the 20 trading days ending on September 14th.
Three University of Massachusetts Amherst scientists have received a four-year, $1.2 million EUREKA grant from the U.S. National Institutes of Health (NIH) to study folding and misfolding of secretory proteins in the cell's protein factory, the endoplasmic reticulum, where misfolding can lead to diseases such as cystic fibrosis and liver cirrhosis.
› Verified 7 days ago
Philip Dean Peterson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-8560 | |
Dr. Byung Jin Kim, M. D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Box 251, Fpo, AP 96362 Phone: 611-743-7285 | |
Tiffany S. Nelson, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 2612, Fpo, AP 96362 Phone: 011-816-117437285 Fax: 011-816-117437408 | |
Dr. Tanya Renee Lindenmuth, D.O. Pathology Medicare: Not Enrolled in Medicare Practice Location: Nmrtc Okinawa Psc 482, Fpo, AP 96362 Phone: 315-646-9643 | |
Patrick Louis Lawson, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Box 1000, Fpo, AP 96362 Phone: 011-819-89717555 |